Us Bancorp \De\ Xencor Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Xencor Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 10,375 shares of XNCR stock, worth $214,451. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,375

Previous 10,907 4.88%

Holding current value

$214,451

Previous $206,000 0.97%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$15.7 - $21.65 $8,352 - $11,517	-532 Reduced 4.88%	10,375 $208,000
Q2 2024 Aug 06, 2024	BUY	$18.21 - $24.5 $156,788 - $210,945	8,610 Added 374.84%	10,907 $206,000
Q1 2024 May 07, 2024	BUY	$18.65 - $26.52 $25,419 - $36,146	1,363 Added 145.93%	2,297 $50,000
Q4 2023 Feb 09, 2024	BUY	$16.53 - $21.42 $12,661 - $16,407	766 Added 455.95%	934 $19,000
Q3 2023 Nov 03, 2023	SELL	$20.08 - $25.39 $7,529 - $9,521	-375 Reduced 69.06%	168 $3,000
Q2 2023 Aug 09, 2023	SELL	$24.77 - $29.9 $1,288 - $1,554	-52 Reduced 8.74%	543 $13,000
Q1 2023 May 09, 2023	SELL	$25.95 - $36.95 $103 - $147	-4 Reduced 0.67%	595 $16,000
Q4 2022 Feb 13, 2023	SELL	$24.79 - $30.86 $11,452 - $14,257	-462 Reduced 43.54%	599 $15,000
Q3 2022 Oct 27, 2022	BUY	$24.62 - $32.44 $3,003 - $3,957	122 Added 12.99%	1,061 $28,000
Q2 2022 Aug 01, 2022	BUY	$19.74 - $29.01 $14,173 - $20,829	718 Added 324.89%	939 $26,000
Q1 2022 May 11, 2022	SELL	$26.68 - $41.63 $160 - $249	-6 Reduced 2.64%	221 $6,000
Q4 2021 Feb 11, 2022	BUY	$33.67 - $43.44 $6,195 - $7,992	184 Added 427.91%	227 $9,000
Q3 2021 Nov 10, 2021	BUY	$30.65 - $35.68 $796 - $927	26 Added 152.94%	43 $1,000
Q4 2020 Feb 04, 2021	BUY	$36.63 - $47.63 $439 - $571	12 Added 240.0%	17 $1,000
Q1 2020 May 13, 2020	SELL	$20.69 - $37.79 $9,062 - $16,552	-438 Reduced 98.87%	5 $0
Q4 2019 Feb 04, 2020	SELL	$32.75 - $41.43 $393 - $497	-12 Reduced 2.64%	443 $15,000
Q3 2019 Nov 08, 2019	BUY	$33.73 - $46.27 $404 - $555	12 Added 2.71%	455 $15,000
Q2 2019 Aug 13, 2019	BUY	$29.6 - $40.93 $11,840 - $16,372	400 Added 930.23%	443 $18,000
Q4 2018 Feb 13, 2019	SELL	$32.39 - $42.05 $11,077 - $14,381	-342 Reduced 88.83%	43 $2,000
Q3 2018 Nov 01, 2018	SELL	$35.69 - $47.65 $16,488 - $22,014	-462 Reduced 54.55%	385 $15,000
Q2 2018 Aug 08, 2018	BUY	$28.41 - $42.41 $24,063 - $35,921	847 New	847 $32,000

Others Institutions Holding XNCR

# of Institutions

216

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.23B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account